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Denmark, 2) Department of Clinical Microbiology and 3) Medical
Department, Viborg Regional Hospital, Viborg, DenmarkAbstractThe role of Fusobacterium necrophorum in tonsillitis in adolescents
and young adults was retrospectively investigated by culture
examination. We compared the prevalence of F. necrophorum in
212 subjects with conﬁrmed clinical tonsillitis and in 176 subjects
with conﬁrmed no clinical tonsillitis. The prevalence of
F. necrophorum was signiﬁcantly higher (p < 0.001) in subjects
with clinical tonsillitis (27%) compared to subjects with no clinical
tonsillitis (6%). These results clearly demonstrate the role of
F. necrophorum in tonsillitis. By diagnosing and treating
F. necrophorum tonsillitis with, for example, penicillin,
metronidazole, or both, we might prevent some cases of
Lemierre syndrome.
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E-mail: anders.jensen@biomed.au.dkFusobacterium necrophorum is the main cause of the life-
threatening disease Lemierre syndrome and is associated with
peritonsillar abscesses [1,2]. Recently several studies haveMicrobiol Infect 2015; 21: 266.e1–266.e3
nical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Infect
p://dx.doi.org/10.1016/j.cmi.2014.09.020suggested that F. necrophorum could be the second most
important bacterial cause of tonsillitis, next to Streptococcus
pyogenes (group A streptococci), but data suggest that
F. necrophorum affects an older age group (10 to 40 years of age)
[3–8]. However, controlled clinical studies have yet to be
conducted using anaerobic culture to detect F. necrophorum in a
deﬁned tonsillitis vs. nontonsillitis group to conﬁrm this.
Results from throat swabs taken from 486 subjects aged 10
to 40 years were retrospectively analysed in our laboratory
between August 2009 and December 2009. Because most
Danish general practitioners use a bedside rapid immunoassay
kit to detect group A streptococcal tonsillitis, most of the
throat swabs were from subjects with a negative streptococcal
A test.
Tonsillitis was deﬁned by the presence of a sore throat,
inﬂamed tonsils, no cough and at least one of the following:
fever, enlarged tender lymphatic glands on the neck, or elevated
C-reactive protein. The tonsillitis subjects thus had at least
three of the four Centor Criteria: history of fever, tonsillar
exudates, no cough, and tender anterior cervical lymphade-
nopathy [9,10]. A nontonsillitis control group consisted of
subjects with throat problems but did not fulﬁll the above
criteria. Also included were throat swabs from febrile subjects
without signs of tonsillitis or from healthy subjects who were
screened for Staphylococcus aureus carriage. From January 2010
to October 2010, a clinical microbiologist either interviewed
the general practitioners or reviewed the medical records and
categorized the subjects as tonsillitis or nontonsillitis according
to the above deﬁnitions. The interviewing clinical microbiologist
was blinded to the culture results; data collection was done
according to national guidelines for patient data handling. Sev-
enty subjects with no or incomplete medical records were
excluded from the study. Tonsillitis subjects were divided into
the following: acute tonsillitis with a single episode, recurrent
tonsillitis with recurrent acute episodes or relapses within 1
month, and chronic cases with a duration of more than 1
month. A total of 212 subjects were categorized as tonsillitis
and 176 subjects as nontonsillitis. In addition, 25 samples were
from subjects with a peritonsillar abscess.
Throat swabs were incubated for 48 hours both aerobically
on blood agar plates with 5% sheep’s blood and anaerobically
on the selective agar plate developed to detect F. necrophorum
[11]. β-Haemolytic streptococci group A, B, C, F and G were
identiﬁed according to standard laboratory procedures, while
F. necrophorum was identiﬁed according to previous published
procedures [12]. All isolated F. necrophorum strains were sus-
ceptible to penicillin, metronidazole and clindamycin. Fisher’s
exact test was used for statistical analysis.ious Diseases. Published by Elsevier Ltd. All rights reserved
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tonsillitis, which was signiﬁcantly (p < 0.001) greater than in our
nontonsillitis group (6%) (Table 1). Even when β-haemolytic
streptococci were excluded from the calculations, the isolation
rate of F. necrophorum was signiﬁcantly higher (p < 0.001) in the
tonsillitis subjects (11%) vs. the nontonsillitis group (3%).
Increasing frequency of F. necrophorum was observed for the
three tonsillitis groups—subjects with acute tonsillitis over
subjects with recurrent tonsillitis to subjects with chronic
tonsillitis (Table 1). Our ﬁndings strongly support the important
role of F. necrophorum in tonsillitis. Although the number of
subjects with recurrent and chronic tonsillitis was low, this
study supports previous ﬁndings that F. necrophorum is espe-
cially involved in recurrent tonsillitis [4,5,7]. F. necrophorum
was also correlated to peritonsillar abscesses in this study
(Table 1).
In a prospective study by Klug et al. [13], a correlation be-
tween F. necrophorum and recurrent tonsillitis was not found.
However, their samples were taken during tonsillectomy where
the subjects had no acute infection in the tonsils, while the
control group consisted of subjects with tonsillar hypertrophy.
In contrast, our samples were taken during an acute throat
infection, which is probably more relevant, as F. necrophorum
infection may be of exogenous origin, as is the case for group A
streptococcal tonsillitis [14]. In subjects with recurrent tonsil-
litis, the bacterium may even drop below the detection limit
during a healthy period.
Because we used a restrictive approach to categorize the
subjects, our nontonsillitis control group might have included
some tonsillitis subjects. However, this miscategorization
would only have increased the frequency of F. necrophorum in
the nontonsillitis group and thereby lowered the signiﬁcance ofTABLE 1. β-Haemolytic streptococci and Fusobacterium necrophorum
subjects with tonsillitis and in the control group, 10 to 40 years of a
Clinical diagnosis
Tonsillitis
Total
(n [ 212)
Acute
(n [ 179)
Recurrent
(n [ 24)
Demography
Age (years), median 19 19 19
Sex, M/F 66/146 59/120 6/18
Microbiologic ﬁndings, n (%)
F. necrophorum 59 (27)*** 43 (23)*** 10 (46)***
F. necrophorum as only pathogen 26 (11)*** 17 (9)* 5 (23)***
Group A streptococci 17 (8)** 7 (4)** 3 (14)**
Group B streptococci 5 (2) 5 (3) 0
Group C streptococci 54 (25)*** 42 (27)** 7 (32)*
F. necrophorum + group C
streptococci
26 (12)*** 20 (12)** 4 (18)*
Group F streptococci 3 (1) 3 (2) 0
Group G streptococci 13 (6) 13 (7) 0
*p <0.05; **p <0.01; ***p <0.001 compared to no tonsillitis.
Clinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and InF. necrophorum as a cause of tonsillitis. Furthermore, our study
design implied that no special attention was made towards
isolation of F. necrophorum for neither the tonsillitis group nor
the nontonsillitis group.
In additions to F. necrophorum, group C streptococci were
also correlated with tonsillitis (Table 1). However,
F. necrophorum was isolated from 48% of the samples positive
for group C streptococci in the tonsillitis group. No correlation
with tonsillitis was found for group C streptococci when
F. necrophorum and other β-haemolytic streptococci were
excluded (data not shown). Our laboratory did not discriminate
between group C streptococci from the Streptococcus anginosus
group and of the species Streptococcus dysgalactiae, which
hampers any further comparison of this correlation. However,
the presence of identical Lanceﬁeld carbohydrate in group C
streptococci may play a role in this correlation. It has previously
been shown that Fusobacterium nucleatum coaggregates in dental
bioﬁlm with certain oral streptococci using a speciﬁc carbo-
hydrate [15]. The same might be the case for F. necrophorum
and group C streptococci in tonsillar bioﬁlms during tonsillitis.
In conclusion, this study strongly demonstrates the impor-
tant role of F. necrophorum in tonsillitis, especially recurrent
tonsillitis. We therefore recommend that all throat swabs from
subjects 10 to 40 years of age with a nonstreptococcal group A
tonsillitis be cultured anaerobically on selective medium to
detect the presence of F. necrophorum. By diagnosing and
treating F. necrophorum tonsillitis with, for example, penicillin,
metronidazole, or both, we might prevent some cases of
Lemierre syndrome. This would be valuable, especially when
we consider that the incidence of Lemierre syndrome is higher
in the tested age group than rheumatic fever and acute
glomerulonephritis after group A throat infection [16,17].found in aerobic and anaerobic cultures of throat swabs from
ge
Peritonsillar abscess
(n [ 25)
No tonsillitis
(n [ 176)
Chronic
(n [ 9)
17 23 22
1/8 6/19 80/96
4 (80)** 8 (32)** 10 (6)
4 (44)** 5 (20)** 5 (3)
0 3 (12)** 0
0 0 2 (1)
1 (20) 3 (12) 22 (12)
2 (22) 1 (4) 6 (3)
0 1 (4) 1 (1)
0 2 (8) 5 (3)
fectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 266.e1–266.e3
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